Iranian Vice-President for Science and Technology Sorena Sattari underlined the country`s billion-dollar income from production of biotech medicine.
`The productions of Iran`s biotech drugs is worth $1.2bln.` Sattari said. addressing the inauguration ceremony of Iran Pharma exhibition in Tehran on Tuesday.
He also asked the traders active in production of biotech drugs to invest in biotech-related food and agricultural fields too.
Iran has taken wide strides in science and technology. particularly in medical and medicinal fields. in recent years.
Biomedicine is a branch of medical science that applies biological and physiological principles to clinical practice. The branch specially applies to biology and physiology.
Biomedicine also can relate to many other categories in health and biological related fields.
Chairman of the Biotechnology Development Council of Iran Mostafa Qaneyee announced in February that 17 countries of the world are at present importing and using the biomedicine products of Iranian scientists.
`Iran enjoys good situation in this field and at present. the biomedicines produced in the country are exported to 17 world states.` Qaneyee said.
He added that production of biomedicine in Iran saves almost $1bln for the country annually.